Aspira Women's Health Inc, Bee Cave, TX, USA.
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, La Jolla, CA, USA.
Curr Med Res Opin. 2020 Dec;36(12):2079-2083. doi: 10.1080/03007995.2020.1842726. Epub 2020 Nov 9.
To assess the use of Multivariate Index Assay (MIA OVA1) by gynecologists and determine referral practices and surgical decision making for women with adnexal masses and low-risk MIA OVA1 scores.
Information on patients who received an OVA1 test was collected retrospectively from 22 gynecologic practices through a chart review. Referral patterns were examined for patients with low-risk OVA1 results prior to first surgical intervention. Chart reviews were from a variety of practice and hospital settings representing major geographic regions within the United States.
A total of 282 independent patient charts were reviewed. Low-risk results were found for 146 patients (52%). Surgery was performed on 82 (56%) patients with low-risk scores. The referral rate to specialty care was 21% (17/82) for low-risk OVA1 patients. Three low-malignant potential tumors were identified in the low-risk patients, with no cases of invasive malignancy. Eighty-six percent of the surgeries performed on low-risk OVA1 patients were minimally invasive. In 44% of the low-risk OVA1 patients, no surgical intervention was performed.
A high proportion of low-risk OVA1 patients were not referred to a gynecologic oncologist prior to surgery, indicating gynecologists may use MIA OVA1 along with clinical and radiographic findings to appropriately retain patients for their care. This practice is safe and may be cost-saving, with patient satisfaction implications.
评估妇科医生对多变量指数分析(MIA OVA1)的使用情况,并确定对附件肿块和低风险 MIA OVA1 评分女性的转诊实践和手术决策。
通过病历回顾,从 22 家妇科诊所收集了接受 OVA1 检测的患者信息。在首次手术干预之前,检查了低风险 OVA1 结果患者的转诊模式。病历回顾来自美国各个主要地理区域的各种实践和医院环境。
共回顾了 282 份独立的患者病历。146 名患者(52%)的结果为低风险。82 名低风险评分患者(56%)进行了手术。低风险 OVA1 患者向专科治疗的转诊率为 21%(17/82)。在低风险患者中发现了 3 个低恶性潜能肿瘤,没有侵袭性恶性肿瘤病例。低风险 OVA1 患者中 86%的手术为微创手术。在 44%的低风险 OVA1 患者中,未进行手术干预。
很大一部分低风险 OVA1 患者在手术前未被转诊至妇科肿瘤医生,这表明妇科医生可能会结合临床和影像学发现,使用 MIA OVA1 适当保留患者接受治疗。这种做法是安全的,并且可能具有成本效益,对患者满意度有影响。